-
My Account
In App
My Account
BSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
NSE Live
Jan 09, 15:40Prev. Close
737.00
Open Price
723.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Remus Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
| Per Share Ratios | |||||
| Basic EPS (Rs.) | 33.75 | 118.72 | 83.24 | 33.86 | |
| Diluted EPS (Rs.) | 33.75 | 118.72 | 83.24 | 33.86 | |
| Cash EPS (Rs.) | 36.96 | 120.27 | 82.77 | 35.41 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 411.24 | 557.11 | 176.36 | 64.32 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 411.24 | 557.11 | 176.36 | 64.32 | |
| Dividend / Share(Rs.) | 1.50 | 6.00 | 2.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 134.40 | 431.07 | 415.00 | 247.17 | |
| PBDIT/Share (Rs.) | 49.05 | 161.15 | 111.74 | 47.91 | |
| PBIT/Share (Rs.) | 45.87 | 155.07 | 107.34 | 46.36 | |
| PBT/Share (Rs.) | 45.23 | 152.92 | 105.20 | 45.49 | |
| Net Profit/Share (Rs.) | 33.79 | 114.19 | 78.37 | 33.86 | |
| Profitability Ratios | |||||
| PBDIT Margin (%) | 36.49 | 37.38 | 26.92 | 19.38 | |
| PBIT Margin (%) | 34.13 | 35.97 | 25.86 | 18.75 | |
| PBT Margin (%) | 33.65 | 35.47 | 25.34 | 18.40 | |
| Net Profit Margin (%) | 25.13 | 26.48 | 18.88 | 13.69 | |
| Return on Networth / Equity (%) | 8.21 | 20.49 | 44.43 | 52.64 | |
| Return on Capital Employed (%) | 10.03 | 27.27 | 43.94 | 69.08 | |
| Return on Assets (%) | 7.09 | 17.15 | 24.53 | 21.28 | |
| Total Debt/Equity (X) | 0.01 | 0.02 | 0.42 | 0.03 | |
| Asset Turnover Ratio (%) | 0.42 | 0.96 | 1.78 | 1.83 | |
| Liquidity Ratios | |||||
| Current Ratio (X) | 4.87 | 3.58 | 1.39 | 0.84 | |
| Quick Ratio (X) | 4.67 | 3.46 | 1.35 | 0.66 | |
| Inventory Turnover Ratio (X) | 41.82 | 65.05 | 0.00 | 0.00 | |
| Dividend Payout Ratio (NP) (%) | 5.92 | 3.50 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 5.42 | 3.32 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 94.08 | 96.50 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 94.58 | 96.68 | 0.00 | 0.00 | |
| Valuation Ratios | |||||
| Enterprise Value (Cr.) | 1,316.51 | 993.87 | 0.00 | 0.00 | |
| EV/Net Operating Revenue (X) | 16.63 | 15.65 | 0.00 | 0.00 | |
| EV/EBITDA (X) | 45.57 | 41.87 | 0.00 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 16.66 | 16.01 | 0.00 | 0.00 | |
| Retention Ratios (%) | 94.07 | 96.49 | 0.00 | 0.00 | |
| Price/BV (X) | 5.44 | 12.38 | 0.00 | 0.00 | |
| Price/Net Operating Revenue | 16.66 | 16.01 | 0.00 | 0.00 | |
| Earnings Yield | 0.02 | 0.02 | 0.00 | 0.00 |
